Bcrx stock after hours

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stock research, profile, news, Avg. 2.61; PE Ratio 0; Shares Outstanding 154.19M; Market Cap 312.24M. Buy or Get Out of the Way. Market players are adding long exposure as the market runs away from them. Jul 27, 2012 11 

Check out our BCRX stock analysis, current BCRX quote, charts, and historical prices for Biocryst Pharma Inc stock InvestorPlace Writer Jan 21, Here's a roundup of top developments in the BCRX - Biocryst Pharma Stock Price - Barchart.com Biocryst Pharma Inc (BCRX) Biocryst Pharma Inc (BCRX) (BCRX) stock based on the movements in the options market lately. BCRX: 1.9100 (-4.02%) During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash"). Volume always reflects consolidated markets. BCRX | BioCryst Pharmaceuticals Inc. Annual Income ... Nov 01, 2019 · Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet.

Discover historical prices for BCRX stock on Yahoo Finance. View daily, weekly or monthly formats back to when BioCryst Pharmaceuticals, Inc. stock was issued.

BCRX Stock Quote - BioCryst Pharmaceuticals, Inc. Common ... Stock quote for BioCryst Pharmaceuticals, Inc. Common Stock Common Stock (BCRX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. BCRX Stock Quote - BioCryst Pharmaceuticals, Inc. Stock ... BCRX stock quote, chart and news. Get BioCryst Pharmaceuticals, Inc.'s stock price today. BioCryst Pharmaceuticals Inc. - NASDAQ:BCRX - Stock Quote ... Mar 27, 2020 · Explore commentary on BioCryst Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about BCRX. BioCryst up 4% after hours on …

Apr 03, 2020 · View today's stock price, news and analysis for BioCryst Pharmaceuticals Inc. (BCRX). Barron's also provides information on historical stock ratings, target prices, company earnings, market

Find out the direct holders, institutional holders and mutual fund holders for BioCryst Pharmaceuticals, Inc. (BCRX). BioCryst up 4% after hours on Point72 stake - BioCryst ... Nov 19, 2019 · BioCryst Pharmaceuticals (NASDAQ:BCRX) perks up 4% after hours on the heels of a disclosure that Steve Cohen's Point72 Asset Management has accumulated a 9.3M-share stake. Biocryst... (BCRX) Stock Quote | Price Chart | Volume Chart

Market Commentary Today’s Market 09:35 Stocks rise in early trading after big banks earnings, E&P megadeal. The major averages are all higher in early trading, with the S&P retaking the 2,900 level after JPMorgan (JPM) and Wells Fargo (WFC) kicked off bank earnings season with better than expected results and Chevron (CVX) announced a huge deal to acquire Anadarko Petroleum (APC) in a stock

BCRX BioCryst Pharmaceuticals Inc Statement of Changes in Beneficial Ownership (4) FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. BCRX Stock Quote of Biocryst Pharma Inc - InvestorPlace Check out our BCRX stock analysis, current BCRX quote, charts, and historical prices for Biocryst Pharma Inc stock InvestorPlace Writer Jan 21, Here's a roundup of top developments in the BCRX - Biocryst Pharma Stock Price - Barchart.com Biocryst Pharma Inc (BCRX) Biocryst Pharma Inc (BCRX) (BCRX) stock based on the movements in the options market lately. BCRX: 1.9100 (-4.02%) During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash"). Volume always reflects consolidated markets. BCRX | BioCryst Pharmaceuticals Inc. Annual Income ...

11 Mar 2020 The institutional investor bought 1.6 million shares of the stock in a After an ongoing check, BioCryst Pharmaceuticals Inc. (BCRX) stock is 

State Street Corp raised its stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) by 13.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,492,943 shares of the biotechnology company’s stock after buying an additional 631,167 shares during the quarter. State Street Corp owned […] BioCryst Pharmaceuticals, Inc. (BCRX) Total Liabilities ...

27 Mar 2020 (BCRX). It is currently valued at $1.99. When the transactions were called off in the previous session, Stock hit the highs of $2.14, after setting-off